GSK granted $1 million for advanced manufacturing project

Healthcare company GSK Australia has received a $1 million grant through the federal government’s Manufacturing Transition Programme. The funding will support GSK’s advanced manufacturing expansion plans at its Boronia site in Melbourne’s outer-eastern suburbs.

The company will expand the site into a full-scale facility for the production of biologicals in ‘blow-fill-seal’ (BFS) packaging. The project will result in the facility being at the forefront of commercialising this state-of-the-art technology, which will further GSK’s leading position as a manufacturer of sterile liquid pharmaceutical products.

Boronia Site Director Dave Morley said the grant will allow GSK’s technical experts to continue to enhance BFS technologies and applications. He stated, “This grant will enable GSK to continue exploring the development of cost-efficient medicines which will not only benefit patients, but also help support the Australian manufacturing sector.

“GSK looks forward to working further in collaboration with government to build Australia’s pharmaceutical manufacturing capabilities, strengthen Australian manufacturing industry amidst a competitive global market and support innovative companies like GSK which strive to provide Australian patients with access to affordable, next-generation medicines,” Morley said.